— Know what they know.
Not Investment Advice

IRME OTC

IR-Med Inc.
1W: +0.0% 1M: +0.0% 3M: -70.0% YTD: -94.8% 1Y: -95.6% 3Y: -99.6% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 52 · $162202 mcap · 29M float · 0.0003% daily turnover · Short 66% of daily vol

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
31
Earnings Quality
18
Growth
49
Value
15
Momentum
51
Safety
0
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-173.62
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
—
—
Ohlson O-Score
59.78
Bankruptcy prob: 100.0%
High Risk
Credit Rating
CCC
Score: 13.1/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.36x
Accruals: -284.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IRME scores -173.62, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IRME scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IRME's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IRME receives an estimated rating of CCC (score: 13.1/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.10x
PEG
-0.00x
P/S
0.00x
P/B
-0.25x
P/FCF
-5.29x
P/OCF
—
EV/EBITDA
-3.29x
EV/Revenue
177.40x
EV/EBIT
-3.26x
EV/FCF
-5.51x
Earnings Yield
-53.10%
FCF Yield
-18.91%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. IRME currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.660
EBT / EBIT
×
EBIT Margin
-54.462
EBIT / Rev
×
Asset Turnover
0.049
Rev / Assets
×
Equity Multiplier
-4.053
Assets / Equity
=
ROE
1793.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IRME's ROE of 1793.9% is driven by Asset Turnover (0.049), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1360 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
255.7%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Oded Bashan –
Executive Chairman
$95,163 $— $394,893
Moshe Gerber -
Chief Executive Officer
$92,896 $— $328,746
Aharon Binur- Development
opment Officer
$126,528 $— $226,262
Dr. Rom Eliaz,
former Chief Executive Officer
$111,038 $— $170,153
Aharon Klein- Technology
nology Officer
$124,954 $— $144,896

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $328,746
Avg Employee Cost (SGA/emp): $410,333
Employees: 3

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3
-72.7% YoY
Revenue / Employee
—
Profit / Employee
$-633,000
NI: $-1,899,000
SGA / Employee
$410,333
Avg labor cost proxy
R&D / Employee
$236,667
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
ROE -10.7% -50.7% -82.0% -1.6% -2.0% -1.3% -1.5% -3.4% -4.4% -2.5% -3.3% -3.3% -5.2% -2.9% -4.8% -53.5% 7.0% 17.9% 17.94%
ROA -9.5% -45.2% -72.9% -1.3% -1.6% -1.2% -1.4% -2.7% -3.0% -2.1% -2.7% -2.3% -2.9% -2.0% -2.5% -3.0% -5.7% -4.4% -4.43%
ROIC 1.4% 8.6% 22.9% 10.9% 15.6% -43.2% -325.2% 28.1% 21.0% 26.8% 28.6% 19.2% 19.1% 11.8% 9.7% 5.8% 3.4% 2.6% 2.64%
ROCE -10.0% -48.1% -77.2% -1.5% -2.3% -87.0% -98.6% -1.8% -2.7% -2.7% -4.7% -9.3% -57.0% -6.7% -18.3% 6.4% 3.0% 2.4% 2.36%
Gross Margin — — — — — — — — — — — 50.0% — — — 50.0% — — —
Operating Margin — — — — — — — — — — — -37.1% — — — -12.5% — — —
Net Margin — — — — — — — — — — — -37.4% — — — -10.7% — — —
EBITDA Margin — — — — — — — — — — — -35.8% — — — -10.5% — — —
FCF Margin — — — — — — — — — — — -95.1% -79.2% -67.6% -55.3% -53.3% -43.8% -32.2% -32.19%
OCF Margin — — — — — — — — — — — -95.1% -79.1% -67.5% -55.3% -53.3% -43.8% -32.2% -32.19%
ROA 3Y Avg snapshot only -6.73%
ROIC Economic snapshot only 3.08%
Cash ROA snapshot only -4.78%
NOPAT Margin snapshot only -44.48%
Pretax Margin snapshot only -90.38%
R&D / Revenue snapshot only 20.58%
SGA / Revenue snapshot only 36.08%
SBC / Revenue snapshot only 12.31%
Valuation
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
P/E Ratio -428.57 -98.58 -52.72 -38.66 -40.38 -25.55 -15.78 -4.06 -3.66 -9.88 -10.92 -16.38 -21.56 -12.14 -12.97 -17.48 -16.97 -1.88 -0.103
P/S Ratio — — — — — — — — — — — 2364.19 2673.83 1240.26 1103.00 1276.86 1315.53 170.20 0.000
P/B Ratio 45.84 49.96 43.22 60.60 149.27 34.25 23.43 13.27 15.49 36.78 70.43 220.23 -1057.10 116.17 18751.08 -112.92 -69.38 -7.08 -0.248
P/FCF -379.81 -192.27 -84.50 -57.17 -84.66 -38.45 -24.13 -10.05 -7.48 -23.55 -26.18 -24.86 -33.77 -18.36 -19.95 -23.95 -30.06 -5.29 -5.287
P/OCF — — — — — — — — — — — — — — — — — — —
EV/EBITDA -432.30 -97.56 -52.04 -38.44 -57.06 -36.49 -21.74 -6.67 -4.71 -13.34 -14.75 -16.46 -21.88 -12.18 -13.22 -17.75 -23.31 -3.29 -3.292
EV/Revenue — — — — — — — — — — — 2347.52 2671.25 1222.73 1096.03 1277.94 1320.84 177.40 177.396
EV/EBIT -431.30 -97.46 -51.98 -38.02 -56.47 -36.03 -21.46 -6.70 -4.73 -13.39 -14.79 -16.25 -21.54 -11.96 -12.94 -17.55 -23.08 -3.26 -3.257
EV/FCF -371.04 -188.24 -82.49 -56.12 -84.02 -37.34 -23.10 -9.25 -6.94 -22.86 -25.76 -24.68 -33.74 -18.10 -19.82 -23.97 -30.18 -5.51 -5.511
Earnings Yield -0.2% -1.0% -1.9% -2.6% -2.5% -3.9% -6.3% -24.6% -27.3% -10.1% -9.2% -6.1% -4.6% -8.2% -7.7% -5.7% -5.9% -53.1% -53.10%
FCF Yield -0.3% -0.5% -1.2% -1.7% -1.2% -2.6% -4.1% -10.0% -13.4% -4.2% -3.8% -4.0% -3.0% -5.4% -5.0% -4.2% -3.3% -18.9% -18.91%
EV/Gross Profit snapshot only 2306.152
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Current Ratio 12.92 14.48 15.42 7.30 3.78 11.42 11.80 4.62 4.61 4.05 2.87 1.79 0.92 2.15 1.18 0.38 0.13 0.12 0.116
Quick Ratio 12.92 14.48 15.42 7.30 3.78 11.42 11.80 4.60 4.61 4.05 2.87 1.79 0.92 2.15 1.18 0.38 0.13 0.12 0.116
Debt/Equity 0.04 0.04 0.05 0.07 0.16 0.06 0.06 0.11 0.11 0.08 0.13 0.55 -3.72 0.43 77.50 -0.53 -0.38 -0.40 -0.400
Net Debt/Equity -1.06 -1.05 -1.03 -1.11 -1.13 -0.98 -1.00 -1.05 -1.12 -1.08 -1.13 -1.55 — -1.64 -118.50 — — — —
Debt/Assets 0.03 0.04 0.05 0.06 0.11 0.05 0.05 0.08 0.08 0.06 0.09 0.20 0.55 0.18 0.29 0.63 1.52 1.43 1.429
Debt/EBITDA -0.38 -0.09 -0.06 -0.05 -0.06 -0.07 -0.06 -0.06 -0.04 -0.03 -0.03 -0.04 -0.08 -0.05 -0.05 -0.08 -0.13 -0.18 -0.178
Net Debt/EBITDA 10.22 2.09 1.27 0.72 0.44 1.08 0.97 0.57 0.37 0.40 0.24 0.12 0.02 0.17 0.08 -0.01 -0.09 -0.13 -0.133
Interest Coverage — -324.50 -190.64 -265.00 -295.14 -448.38 — -168.86 -186.68 -144.76 -153.43 -545.67 -468.56 -434.38 -359.88 -189.30 -2.81 -1.51 -1.511
Equity Multiplier 1.13 1.12 1.12 1.24 1.53 1.16 1.15 1.27 1.38 1.31 1.46 2.74 -6.73 2.44 266.50 -0.85 -0.25 -0.28 -0.280
Cash Ratio snapshot only 0.081
Debt Service Coverage snapshot only -1.495
Cash to Debt snapshot only 0.252
FCF to Debt snapshot only -3.348
Defensive Interval snapshot only 22.5 days
Efficiency & Turnover
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.03 0.04 0.07 0.05 0.049
Inventory Turnover — — — — — — — 1.67 48378511622144000.00 — — 5.73 — — — — — — —
Receivables Turnover (trade) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.61 0.50 0.51 0.33 0.61 0.83 0.825
Payables Turnover — 0.01 0.01 0.09 0.02 0.03 0.04 0.16 0.02 0.04 0.05 0.54 0.08 0.08 0.09 0.50 0.09 0.11 0.111
DSO (trade) — — — — — — — — — — — 730 596 725 719 1102 597 442 442.2 days
DIO 0 0 0 0 0 -0 0 218 0 -0 -1 64 -0 0 -0 -0 -0 0 0.0 days
DPO 0 54568 28957 4234 15095 13566 8608 2245 17371 8749 7890 682 4553 4359 4203 730 4220 3285 3285.0 days
Cash Conversion Cycle (trade) — — — — — — — — — — — 112 -3957 -3634 -3484 372 -3624 -2843 -2842.8 days
Fixed Asset Turnover snapshot only 0.351
Cash Velocity snapshot only 0.413
Capital Intensity snapshot only 6.731
Growth (YoY)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Revenue — — — — — — — — — — — — — — — -23.5% -23.5% -23.5% -23.53%
Net Income — — — — -12.1% -1.6% -97.1% -1.3% -24.9% -43.5% -47.1% 42.1% 42.0% 53.5% 63.0% 61.3% 52.2% 32.3% 32.34%
EPS — — — — -11.7% -1.5% -85.3% -1.2% -18.5% -41.8% -46.8% 43.0% 42.9% 54.4% 64.0% 61.9% 53.1% 35.5% 35.52%
FCF — — — — -4.5% -2.4% -1.1% -36.3% -28.2% 9.4% 6.2% 5.6% 24.4% 26.8% 42.3% 57.1% 57.7% 63.6% 63.56%
EBITDA — — — — -8.5% -82.1% -38.5% -29.5% -28.4% -51.7% -54.2% -2.1% 20.9% 36.5% 50.5% 61.4% 64.5% 59.0% 58.97%
Op. Income — — — — -8.5% -82.4% -38.8% -29.6% -28.4% -51.8% -54.1% -3.1% 19.8% 35.5% 49.6% 60.5% 63.6% 57.9% 57.87%
OCF Growth snapshot only 63.53%
Asset Growth snapshot only -80.27%
Equity Growth snapshot only -2.72%
Debt Growth snapshot only 59.24%
Shares Change snapshot only 4.94%
Growth (CAGR)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Revenue 3Y — — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — -50.2% -41.1% -47.6% -56.0% -62.8% -66.1% -66.10%
Assets 5Y — — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — — -54.6% -91.5% — — — —
Book Value 3Y — — — — — — — — — — — — — -55.9% -91.8% — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Revenue Stability — — — — — — — — 1.00 1.00 1.00 0.75 0.60 0.60 0.60 0.67 0.67 0.67 0.673
Earnings Stability — — — — — — — — 0.90 0.99 1.00 0.06 0.31 0.14 0.03 0.18 0.01 0.00 0.005
Margin Stability — — — — — — — — — — — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.90 0.83 0.81 0.83 0.83 0.50 0.50 0.50 0.50 0.87 0.871
Earnings Smoothness — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -2.33 -2.80 -5.30 -11.03 — -7.04 -1442.03 — — — —
Gross Margin Trend — — — — — — — — — — — — — — — — — — —
FCF Margin Trend — — — — — — — — — — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
OCF/Net Income 1.11 0.51 0.62 0.67 0.47 0.65 0.64 0.40 0.48 0.42 0.42 0.66 0.64 0.66 0.65 0.73 0.56 0.36 0.356
FCF/OCF 1.01 1.01 1.01 1.01 1.01 1.02 1.02 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.356
CapEx/Revenue — — — — — — — — — — — 5.9% 5.9% 5.9% 2.9% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio 0.01 -0.22 -0.28 -0.42 -0.87 -0.41 -0.48 -1.64 -1.57 -1.22 -1.55 -0.78 -1.03 -0.67 -0.88 -0.82 -2.50 -2.85 -2.849
Sloan Accruals snapshot only -2.111
Dividends & Buybacks
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -1.7% -1.7% -2.4% -2.4% -0.1% -2.5% -4.5% -19.8% -25.6% -6.3% -4.9% -1.2% -1.1% -1.7% -2.0% -2.3% -2.2% -2.9% -2.89%
Total Shareholder Return -1.7% -1.7% -2.4% -2.4% -0.1% -2.5% -4.5% -19.8% -25.6% -6.3% -4.9% -1.2% -1.1% -1.7% -2.0% -2.3% -2.2% -2.9% -2.89%
DuPont Factors
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.41 1.47 1.45 1.79 1.39 1.38 1.36 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.03 1.01 1.01 1.00 1.00 0.99 0.98 1.00 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.35 1.66 1.660
EBIT Margin — — — — — — — — — — — -144.44 -124.03 -102.21 -84.68 -72.81 -57.23 -54.46 -54.462
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.03 0.04 0.07 0.05 0.049
Equity Multiplier 1.13 1.12 1.12 1.24 1.24 1.14 1.14 1.26 1.45 1.21 1.23 1.45 1.81 1.48 1.90 17.61 -1.21 -4.05 -4.053
Per Share
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
EPS (Diluted TTM) $-0.01 $-0.03 $-0.04 $-0.06 $-0.09 $-0.08 $-0.08 $-0.12 $-0.11 $-0.11 $-0.11 $-0.07 $-0.06 $-0.05 $-0.04 $-0.03 $-0.03 $-0.03 $-0.03
Book Value/Share $0.07 $0.06 $0.05 $0.04 $0.02 $0.06 $0.05 $0.04 $0.02 $0.03 $0.02 $0.01 $-0.00 $0.01 $0.00 $-0.00 $-0.01 $-0.01 $-0.01
Tangible Book/Share $0.07 $0.06 $0.05 $0.04 $0.02 $0.06 $0.05 $0.04 $0.02 $0.03 $0.02 $0.01 $-0.00 $0.01 $0.00 $-0.00 $-0.01 $-0.01 $-0.01
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.01 $-0.02 $-0.03 $-0.04 $-0.04 $-0.05 $-0.05 $-0.05 $-0.05 $-0.05 $-0.05 $-0.05 $-0.04 $-0.03 $-0.03 $-0.02 $-0.02 $-0.01 $-0.00
OCF/Share $-0.01 $-0.02 $-0.03 $-0.04 $-0.04 $-0.05 $-0.05 $-0.05 $-0.05 $-0.05 $-0.05 $-0.05 $-0.04 $-0.03 $-0.03 $-0.02 $-0.02 $-0.01 $-0.00
Cash/Share $0.07 $0.07 $0.05 $0.04 $0.03 $0.06 $0.06 $0.04 $0.03 $0.03 $0.02 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00
EBITDA/Share $-0.01 $-0.03 $-0.04 $-0.06 $-0.06 $-0.05 $-0.05 $-0.07 $-0.08 $-0.08 $-0.08 $-0.07 $-0.06 $-0.05 $-0.04 $-0.03 $-0.02 $-0.02 $-0.02
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-0.07 $-0.06 $-0.05 $-0.04 $-0.03 $-0.06 $-0.05 $-0.04 $-0.03 $-0.03 $-0.02 $-0.01 $-0.00 $-0.01 $-0.00 $0.00 $0.00 $0.00 $0.00
Academic Models
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — -173.620
Altman Z-Prime snapshot only -413.470
Piotroski F-Score 1 2 2 2 1 1 1 1 3 1 1 3 3 3 3 3 3 2 2
Beneish M-Score — — — — — — — — — — — — — — — -12.00 — — —
Ohlson O-Score snapshot only 59.777
Net-Net WC snapshot only $-0.01
Credit
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Current
Credit Rating snapshot only CCC
Credit Score 73.44 59.74 59.52 61.07 62.18 63.66 75.07 65.15 63.70 64.34 63.11 58.03 20.00 61.89 16.47 12.97 13.11 13.12 13.119
Credit Grade snapshot only 17
Credit Trend snapshot only -48.770
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 2
Sector Credit Rank snapshot only 1

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms